# Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients

> **NCT03344627** · NA · COMPLETED · sponsor: **Mahidol University** · enrollment: 76 (actual)

## Conditions studied

- Sepsis
- Septic Shock
- Critical Illness
- Carbapenem
- Pharmacokinetic
- Pharmacodynamic
- Clinical Outcome
- Organ Failure, Multiple
- Morality

## Interventions

- **DRUG:** Meropenem standard dose
- **DRUG:** Meropenem high dose

## Key facts

- **NCT ID:** NCT03344627
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-27
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2019-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03344627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03344627, "Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03344627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*